Lv11
80 积分 2023-10-16 加入
Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM): Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti‐PLA2R positive primary membranous nephropathy
6小时前
已完结
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
4天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
11天前
已完结
A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts
22天前
已完结
Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format
2个月前
已完结
Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment
2个月前
已完结
An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies
2个月前
已完结
Development of biparatopic bispecific antibody possessing tetravalent scFv-Fc capable of binding to ROBO1 expressed in hepatocellular carcinoma cells
2个月前
已完结
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis
2个月前
已完结
Chronic kidney disease
3个月前
已完结
皖公网安备34019202002308
